glp-1 and glp-2 drugs medications linked to major drop in pancreatic, colorectal cancer risk https://www.medicalnewstoday.com/articles/weight-loss-drugs-glp-1 -slash-risk-4-types-cancer-50-or-more-study GLP-1 Drug Savings: A Complete
Description
doi: 10.1093/ajcn/nqaa086
Eli Lillys diabetes drug Mounjaro has just been approved for obesity in the UK and it is developing another weight-loss drug, Retatrutide
Risk of fracture in women with type 2 diabetes: the women's health initiative observational study
Semaglutide prescribing information: Gastrointestinal adverse reactions
Licensed indication : The same active ingredient may be marketed under different brand names for diabetes versus obesity (e.g., Ozempic vs Wegovy for semaglutide), with different pricing structures
